A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma

A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma

BackgroundClear cell renal cell carcinoma (ccRCC) is a malignant disease containing tumor-infiltrating lymphocytes. Reactive oxygen species (ROS) are present in the tumor microenvironment and are strongly associated with cancer development. Nevertheless, the role of ROS-related genes in ccRCC remain...

Full description

Bibliographic Details
Main Authors:	Hongxiang Liu, Yong Luo, Shankun Zhao, Jing Tan, Minjian Chen, Xihai Liu, Jianheng Ye, Shanghua Cai, Yulin Deng, Jinchuang Li, Huichan He, Xin Zhang, Weide Zhong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Oncology
Subjects:	clear cell renal cell carcinoma reactive oxygen species prognosis immune infiltrates immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1202151/full

Similar Items

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
by: Yulin Deng, et al.
Published: (2022-11-01)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
by: Yuanfa Feng, et al.
Published: (2023-03-01)

Identification and validation of a signature involving voltage-gated chloride ion channel genes for prediction of prostate cancer recurrence
by: Yong Luo, et al.
Published: (2022-09-01)

MYPT1 inhibits the metastasis of renal clear cell carcinoma via the MAPK8/N‐cadherin pathway
by: Qingling Xie, et al.
Published: (2022-11-01)

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer
by: Zhihao Zou, et al.
Published: (2021-08-01)

TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
by: Xuejin Zhu, et al.
Published: (2021-03-01)

Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
by: Xuejin Zhu, et al.
Published: (2021-08-01)

Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy
by: Yong Luo, et al.
Published: (2022-08-01)

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
by: Zhaodong Han, et al.
Published: (2022-04-01)

Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis
by: Weimin Zhong, et al.
Published: (2021-06-01)

Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
by: Xin Wu, et al.
Published: (2023-01-01)

Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma
by: Zhenwei Wang, et al.
Published: (2024-04-01)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
by: Jin Zhang, et al.
Published: (2020-12-01)

Practicing Ballot Secrecy: Postal Voting and the Witness Requirement at the 2019 Finnish Elections
by: Marjukka Weide, et al.
Published: (2021-07-01)

A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma
by: Kun Meng, et al.
Published: (2023-01-01)

Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma
by: Qihang Wu, et al.
Published: (2023-10-01)

A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
by: Zhiyuan Li, et al.
Published: (2022-09-01)

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
by: Jianheng Ye, et al.
Published: (2023-08-01)

Effects of a dressing device and an improved coolant system on grinding of glass
by: Liu, Weide.
Published: (2008)

Image segmentation with less manual labeling effort
by: Liu, Weide
Published: (2022)

Remote control for Nao humanoid robot
by: Liu, Weide
Published: (2016)

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma
by: Qingxin Yu, et al.
Published: (2022-08-01)

Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma
by: Suhua Gao, et al.
Published: (2021-02-01)

Immune Infiltration Landscape in Clear Cell Renal Cell Carcinoma Implications
by: Yongfeng Wang, et al.
Published: (2021-02-01)

Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures
by: Ying Tong, et al.
Published: (2021-12-01)

ASNS can predict the poor prognosis of clear cell renal cell carcinoma
by: Xinqiang Gan, et al.
Published: (2022-08-01)

The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer
by: Wei Zhang, et al.
Published: (2022-12-01)

SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
by: Huayi Feng, et al.
Published: (2022-12-01)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
by: Rui Zhou, et al.
Published: (2021-09-01)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
by: Xueting Ren, et al.
Published: (2021-08-01)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
by: Tianming Ma, et al.
Published: (2021-10-01)

Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma
by: Zhengqi Wu, et al.
Published: (2023-12-01)

High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
by: Yuting Tang, et al.
Published: (2022-12-01)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
by: Silin Jiang, et al.
Published: (2023-08-01)

Identification of Hypoxia–Immune-Related Gene Signatures and Construction of a Prognostic Model in Kidney Renal Clear Cell Carcinoma
by: Shuheng Bai, et al.
Published: (2022-02-01)

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma
by: Zhuo Chen, et al.
Published: (2022-10-01)

Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
by: Jing Chen, et al.
Published: (2020-05-01)

FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation
by: Ren Liu, et al.
Published: (2024-01-01)

NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma
by: Baishu Zheng, et al.
Published: (2023-05-01)

The vasculogenic mimicry related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma
by: Yuming Gu, et al.
Published: (2024-04-01)